Minerva Neurosciences (NERV) Priced

Clinical-stage biotech developing treatments for central nervous system diseases.

Health Care - Biotechnology

IPO Performance
Latest Trade $9.40 0.00 (0.0%)
First Day Return 0.8%
Return from IPO 56.7%
 
Minerva Neurosciences IPO News more
  • .
IPO Data
IPO File Date 04/09/2014
Offer Price $6.00
Price Range $6.00 - $6.00
Offer Shares (mm) 5.5
Deal Size ($mm) 33
 
IPO Data
IPO Date 06/30/2014
Offer Price $6.00
Price Range $6.00 - $6.00
Offer Shares (mm) 5.5
Deal Size ($mm) $33
 
Underwriters
more
Business Overview
Clinical-stage biotech developing treatments for central nervous system diseases.
Clinical-stage biotech developing treatments for central nervous system diseases.
more
Company Data
Headquarters Cambridge, MA
Founded 2007
Employees 6
Website www.minervaneurosciences.com
 

Performance vs. IPO Index (IPOUSA)